Trade Summary

Yesterday, Davis George Eric, serving as EVP, GC at Biomarin Pharmaceutical Inc (BMRN), sold 26,061 shares at $61.36 per share, for a total transaction value of $1,599,103.00. Following this transaction, Davis George Eric now holds 72,453 shares of BMRN.

This sale represents a 26.00% decrease in Davis George Eric's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, February 26, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, meaning the disclosure happened on the same day as the trade.

Biomarin Pharmaceutical Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.